Literature DB >> 18617739

The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.

I H G B Ramakers1, P J Visser, P Aalten, O Bekers, K Sleegers, C L van Broeckhoven, J Jolles, F R J Verhey.   

Abstract

BACKGROUND: Memory problems are a main feature of mild cognitive impairment (MCI) and may be related to the apolipoprotein E (APOE) epsilon4 allele. We investigated whether the effect of the APOE genotype on memory in subjects with MCI was dependent on age and underlying Alzheimer disease (AD) pathology.
METHODS: Subjects with MCI (n = 180) were selected from a memory clinic setting. Subjects with at least one APOE epsilon4 allele (n = 83) were compared to non-carriers on several memory measures. Subjects were reassessed 5-10 years later in order to identify those who developed AD.
RESULTS: In the middle-aged subgroup, the APOE epsilon4 allele was most strongly related to decreased subjective organization and in the old subgroup to a decreased delayed recall. After excluding subjects with incipient AD (n = 33), results remained similar in the middle-aged subgroup, but in the old subgroup the APOE genotype was no longer associated with memory dysfunction.
CONCLUSION: The presence of the APOE epsilon4 allele is associated with impaired memory functioning in both middle-aged and old subjects with MCI, although the memory function affected varies with age. Its effect on memory function may be dependent on underlying AD pathology in elderly subjects, but not in middle-aged subjects. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617739     DOI: 10.1159/000144072

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

Review 1.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

Review 2.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.

Authors:  Christiane Reitz
Journal:  Expert Rev Mol Diagn       Date:  2015-01-29       Impact factor: 5.225

Review 3.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

4.  Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.

Authors:  Danielle C Whitehair; Abdullah Sherzai; Jennifer Emond; Rema Raman; Paul S Aisen; Ronald C Petersen; Adam S Fleisher
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

5.  Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults.

Authors:  Lorna W Harries; Rachel M Bradley-Smith; David J Llewellyn; Luke C Pilling; Alexander Fellows; William Henley; Dena Hernandez; Jack M Guralnik; Stefania Bandinelli; Andrew Singleton; Luigi Ferrucci; David Melzer
Journal:  Rejuvenation Res       Date:  2012-05-18       Impact factor: 4.663

6.  Hierarchical cognitive and psychosocial predictors of amnestic mild cognitive impairment.

Authors:  S Duke Han; Hideo Suzuki; Amy J Jak; Yu-Ling Chang; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2010-07       Impact factor: 2.892

7.  Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy.

Authors:  Timothy S Chang; Michael H Coen; Asenath La Rue; Erin Jonaitis; Rebecca L Koscik; Bruce Hermann; Mark A Sager
Journal:  J Int Neuropsychol Soc       Date:  2012-02-10       Impact factor: 2.892

8.  The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Jeremiah F Kelly; David A Bennett
Journal:  Neuroepidemiology       Date:  2009-11-11       Impact factor: 3.282

Review 9.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

Review 10.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.